Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05924087Recruiting

Interventional Therapy of Tracheal Stenosis

Role: lead

NCT05058469Unknown

Tracheotomy With and Without Dual Antiplatelet Therapy

Role: lead

NCT05054556Unknown

Galectin and Respiratory Weaning

Role: lead

NCT05496504Completed

Pulmonary Hypertension and Arrhythmia

Role: lead

NCT04630236Not ApplicableCompleted

Ultrasound Guided Positioning of Central Venous Catheters

Role: lead

NCT03082339Completed

Cortisone and QTc-Interval

Role: lead

All 6 trials loaded